Smoking reduces the efficacy of intravesical bacillus Calmette- Guérin immunotherapy in non-muscle-invasive bladder cancer

European Urology

Volumn 62, Issue 6, 2012, Pages 1204-1206

  Rink, Michael ^a,b   Xylinas, Evanguelos ^a,c   Babjuk, Marko ^d   Pycha, Armin ^e   Karakiewicz, Pierre I ^f   Novara, Giacomo ^g   Dahlem, Roland ^b   Shariat, Shahrokh F ^a,h  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Paris Descartes University ^*  (France)

^d UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^e CENTRAL HOSPITAL OF BOLZANO   (Italy)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSITY OF PADOVA   (Italy)

^h NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DOXORUBICIN; EPIRUBICIN; MITOMYCIN;

CANCER GROWTH; CANCER IMMUNOTHERAPY; CAUSE OF DEATH; CHEMOTHERAPY; CLINICAL DECISION MAKING; CYSTOSCOPY; DRUG EFFICACY; FOLLOW UP; HAZARD RATIO; HUMAN; LETTER; LONG TERM CARE; NON MUSCLE INVASIVE BLADDER CANCER; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT; SINGLE DRUG DOSE; SMOKING; TRANSITIONAL CELL CARCINOMA;

ADJUVANTS, IMMUNOLOGIC; AGED; BCG VACCINE; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SMOKING; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84868527697     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.08.057     Document Type: Letter

References (8)

1. M. Babjuk, W. Oosterlinck, and R. Sylvester EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 2011 997 1008
2. R.J. Sylvester, M.A. van der, and D.L. Lamm Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials J Urol 168 2002 1964 1970
3. P. Aveyard, P. Adab, and K.K. Cheng Does smoking status influence the prognosis of bladder cancer? A systematic review BJU Int 90 2002 228 239
4. R.J. Lammers, W.P. Witjes, and K. Hendricksen Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer Eur Urol 60 2011 713 720
5. J.P. Sfakianos, S.F. Shariat, R.L. Favaretto, J. Rioja, and H.W. Herr Impact of smoking on outcomes after intravesical bacillus Calmette-Guerin therapy for urothelial carcinoma not invading muscle of the bladder BJU Int 108 2011 526 530
6. Rink M, Furberg H, Zabor EC, et al. Impact of smoking and smoking cessation on oncological outcomes in primary non-muscle-invasive bladder cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.08.025.
7. M. Rink, H. Fajkovic, and E.K. Cha Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma Eur Urol 61 2012 854 855
8. M. Sopori Effects of cigarette smoke on the immune system Nat Rev Immunol 2 2002 372 377